Cargando…
Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310488/ https://www.ncbi.nlm.nih.gov/pubmed/37312586 http://dx.doi.org/10.5045/br.2023.2023061 |
| _version_ | 1785066552251383808 |
|---|---|
| author | Mekni, Sabrine Kanoun, Rimmel Yosra Ladeb, Saloua Belloumi, Dorra Abdeljelil, Nour Ben Othman, Tarek Ben |
| author_facet | Mekni, Sabrine Kanoun, Rimmel Yosra Ladeb, Saloua Belloumi, Dorra Abdeljelil, Nour Ben Othman, Tarek Ben |
| author_sort | Mekni, Sabrine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10310488 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103104882023-07-01 Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report Mekni, Sabrine Kanoun, Rimmel Yosra Ladeb, Saloua Belloumi, Dorra Abdeljelil, Nour Ben Othman, Tarek Ben Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2023-06-30 2023-06-14 /pmc/articles/PMC10310488/ /pubmed/37312586 http://dx.doi.org/10.5045/br.2023.2023061 Text en © 2023 Korean Society of Hematology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Mekni, Sabrine Kanoun, Rimmel Yosra Ladeb, Saloua Belloumi, Dorra Abdeljelil, Nour Ben Othman, Tarek Ben Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report |
| title | Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report |
| title_full | Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report |
| title_fullStr | Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report |
| title_full_unstemmed | Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report |
| title_short | Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report |
| title_sort | venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310488/ https://www.ncbi.nlm.nih.gov/pubmed/37312586 http://dx.doi.org/10.5045/br.2023.2023061 |
| work_keys_str_mv | AT meknisabrine venetoclaxazacitidineassalvagetherapyforrelapsedmixedphenotypeacuteleukemiaafterasecondallogeneichematopoieticstemcelltransplantationacasereport AT kanounrimmelyosra venetoclaxazacitidineassalvagetherapyforrelapsedmixedphenotypeacuteleukemiaafterasecondallogeneichematopoieticstemcelltransplantationacasereport AT ladebsaloua venetoclaxazacitidineassalvagetherapyforrelapsedmixedphenotypeacuteleukemiaafterasecondallogeneichematopoieticstemcelltransplantationacasereport AT belloumidorra venetoclaxazacitidineassalvagetherapyforrelapsedmixedphenotypeacuteleukemiaafterasecondallogeneichematopoieticstemcelltransplantationacasereport AT abdeljelilnourben venetoclaxazacitidineassalvagetherapyforrelapsedmixedphenotypeacuteleukemiaafterasecondallogeneichematopoieticstemcelltransplantationacasereport AT othmantarekben venetoclaxazacitidineassalvagetherapyforrelapsedmixedphenotypeacuteleukemiaafterasecondallogeneichematopoieticstemcelltransplantationacasereport |